GlobeNewswire PharmaOriginal article
Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.
PartnershipPositive
AI Analysis
Summary
Teva Pharmaceuticals announced an intent to reach an agreement with the Trump Administration to lower costs of select medicines for Medicaid-covered patients while supporting domestic manufacturing and continued innovation investment. The agreement would align U.S. Medicaid pricing with leading developed markets and include a prospective MFN commitment for future launches.
Outcome Details
Intent to reach agreement on affordable medicines and supply chain security; negotiations ongoing with conditions remaining confidential
Importance:6/10
Sentiment:
0.60
drug pricingMedicaidgovernment affairssupply chainmost-favored-nation pricingdomestic manufacturing
Related Companies
Read the original article
Published by GlobeNewswire Pharma on August 31, 2026 8:07 PM